The place of beta 2 glycoprotein 1 in the assessment of antiphospholipid syndrome
Development of an experimental model of pre-thrombosis in rats based on Wessler's principle using a calibrated venous stasis
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis
Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients
Reactive hyperemia and tissue-type plasminogen activator release in hypertensive men
Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol
Görög Thrombosis Test
Ex-vivo regulation of endotoxin-induced tissue factor in whole blood by eicosanoids
Coagulation factor V G allele and HR2 haplotype
Antiphospholipid antibodies in young women with and without oral contraceptive use
Idraparinux and liver enzymes
Pre-thrombotic state and impaired fibrinolytic potential in coronary heart disease patients with left ventricular dysfunction
Thrombotic thrombocytopenic purpura–hemolytic uremic syndrome after bupropion treatment for smoking cessation
Right ventricular mass and pulmonary embolism in a patient with essential thrombocythemia
Ischaemic strokes and homozygosity for the α2 807T allele of the platelet collagen receptor in young monozygotic twins
Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy
Severe venous thromboembolism in a young man with Klinefelter's syndrome and heterozygosis for both G20210A prothrombin and factor V Leiden mutations
A differentiated approach to assess the diagnostic usefulness of a rapid particle gel immunoassay for the detection of antibodies against heparin-platelet factor 4 in cardiac surgery patients
A splicing donor site point mutation in intron 6 of the plasmin inhibitor (α2 antiplasmin) gene with heterozygous deficiency and a bleeding tendency
Association of anti-heparin platelet factor 4 antibody levels and thrombosis in pediatric intensive care patients without thrombocytopenia
Recombinant factor VIIa in preterm neonates with prolonged prothrombin time